Characterization of <i>Escherichia coli</i> NDM isolates with decreased susceptibility to aztreonam/avibactam: role of a novel insertion in PBP3

Richard A. Alm(AstraZeneca (United States)), Sushmita D. Lahiri(AstraZeneca (United States))

Journal of Antimicrobial Chemotherapy

January 28, 2015

10.1093/jac/dku568

Cited by 179

Related Papers

No related papers found

Powered by citation graph analysis